Viewing Study NCT03082768


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-02-25 @ 8:48 PM
Study NCT ID: NCT03082768
Status: COMPLETED
Last Update Posted: 2018-03-06
First Post: 2017-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects
Sponsor: Molecular NeuroImaging
Organization:

Study Overview

Official Title: An Open Label, Brain Positron Emission Tomography, Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects
Status: COMPLETED
Status Verified Date: 2018-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The overall goal of this protocol is to evaluate \[18F\]MNI-968 (aka PF-06730110) as a D1 receptor targeted radiopharmaceutical.
Detailed Description: The overall goal of this protocol is to evaluate \[18F\]MNI-968 (aka PF-06730110) as a D1 receptor targeted radiopharmaceutical.

* To measure the dynamic uptake and washout of \[18F\]MNI-968 in brain using positron emission tomography (PET) in healthy volunteers.
* To measure blood metabolites of \[18F\]MNI-968 in the healthy volunteers and to perform invasive as well as non-invasive modeling to assess \[18F\]MNI-968 binding to D1 receptor.
* To acquire safety data following injection of \[18F\]MNI-968
* Evaluation of \[18F\]MNI-968 PET reliability (test/retest) of several outcome measures

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: